Why is Biofil Chemicals falling/rising?

As of 30-Jun, Biofil Chemicals & Pharmaceuticals Ltd is experiencing a slight decline in its stock price, currently at 47.34, with a change of -0.06, representing a decrease of 0.13%. The stock has been underperforming, having lost 2.19% over the last two days and is currently lower than the 20-day, 50-day, 100-day, and 200-day moving averages, although it remains higher than the 5-day moving average. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 63.46% compared to the 5-day average. The stock's performance over the past month shows a decline of 4.36%, and it has underperformed the benchmark Sensex, which has risen by 2.65% during the same period.
Broader Market Context: In the short term, Biofil Chemicals has not kept pace with the benchmark, as evidenced by its 1-week return of +1.81% compared to the Sensex's +2.09%. The stock's year-to-date performance is particularly concerning, with a decline of 16.95% against the Sensex's gain of 7.00%. This broader market context indicates that while the overall market is experiencing growth, Biofil Chemicals is struggling, which may be contributing to the recent downward pressure on its stock price.